PRLD - Prelude Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PRLD is currently covered by 2 analysts with an average price target of $7. This is a potential upside of $1.51 (48.94%) from yesterday's end of day stock price of $4.7.

Prelude Therapeutics 's activity chart (see below) currently has 27 price targets and 36 ratings on display. The stock rating distribution of PRLD is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 45.36% with an average time for these price targets to be met of 155.22 days.

Highest price target for PRLD is $8, Lowest price target is $6, average price target is $7.

Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 29-Jul-2026. First documented stock forecast 20-Oct-2020.

Best performing analysts who are covering PRLD - Prelude Therapeutics :

Tazeen Ahmad Reni Benjamin Robert Burns Jeffrey Hung Peter Lawson Roger Song

Currently out of the existing stock ratings of PRLD, 4 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-Oct-2024

$8

$3.13 (64.27%)

$8

1 months 24 days ago
(29-Jul-2026)

10/17 (58.82%)

$3.29 (69.85%)

291

Buy Since 13-Mar-2024

$6

$1.62 (36.99%)

6 months 10 days ago
(11-Mar-2026)

3/6 (50%)

$2.19 (57.48%)

406

Sell Since 28-Oct-2024

$1

$-3.38 (-77.17%)

1 years 10 months 24 days ago
(28-Oct-2024)

1/3 (33.33%)

$-0.5 (-33.33%)

21

Sell Since 19-Dec-2023

$4

$-0.08 (-1.96%)

$10

2 years 9 months 3 days ago
(19-Dec-2023)

2/7 (28.57%)

$-0.04 (-0.99%)

4

Sell Since 21-Nov-2022

$6

$1.92 (47.06%)

3 years 10 months 1 days ago
(21-Nov-2022)

3/4 (75%)

$-0.53 (-8.12%)

18

Show more analysts

Please expand the browser size to see the chart

What is PRLD (Prelude Therapeutics ) average time for price targets to be met?

On average it took 155 days for the stock forecasts to be reached, with an average price target met ratio of 45.36%.

Which analyst most recently updated their price target on PRLD (Prelude Therapeutics )?

Robert Burns

Which analyst has the most public recommendations on PRLD (Prelude Therapeutics )?

Robert Burns has 42 price targets and 27 ratings on PRLD

Which analyst is the currently most bullish on PRLD (Prelude Therapeutics )?

Roger Song with the highest potential upside of $4.92

Which analyst is the currently most reserved on PRLD (Prelude Therapeutics )?

Peter Lawson with the lowest potential downside of -$3.87

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?